In life sciences licensing and collaboration agreements, business leaders often rely on legal teams to negotiate key terms that have significant financial implications. However, many such negotiations devolve into trading points, relative to often-imprecise, aggregated perceived “market terms”, rather than addressing the underlying economic or product rationales. This session will empower business leaders to better understand and thereby aptly spearhead such critical agreement terms’ negotiations, bridging the gap between negotiation tactics and strategic business outcomes.
- How to analyze and address the economic or product rationales behind common licensing and collaboration agreements’ terms, such as payment offsets or IP constructs.
- Strategies for aligning business goals with legal negotiations to ensure swift agreement terms resolutions.
- In-depth advice for business leaders to actively participate in resolving key licensing issues.
